 | • レポートコード：MRC2012A1443 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ブルーアイ病ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ブルーアイ病ワクチンの種類別市場規模（生ワクチン、不活化ワクチン）、用途別市場規模（子豚、成豚）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：CAHIC、Ringpu Biology、Chopper Biology、Merial、Veterinary、MSD Animal Health、DHN、ChengDu Tecbond、Ceva、Qilu Animal、 ・地域別グローバル市場分析 2015年-2020年 ・ブルーアイ病ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・ブルーアイ病ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ブルーアイ病ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ブルーアイ病ワクチンの南米市場（ブラジル、アルゼンチン） ・ブルーアイ病ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：生ワクチン、不活化ワクチン ・用途別分析：子豚、成豚 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Blue Eye Disease Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Blue Eye Disease Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Blue Eye Disease Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Blue Eye Disease Vaccines market has been segmented into
Live Vaccines
Killed Vaccines
By Application, Blue Eye Disease Vaccines has been segmented into:
Piglets
Adult Pigs
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Blue Eye Disease Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Blue Eye Disease Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Blue Eye Disease Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Blue Eye Disease Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Blue Eye Disease Vaccines Market Share Analysis
Blue Eye Disease Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Blue Eye Disease Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Blue Eye Disease Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Blue Eye Disease Vaccines are:
CAHIC
Ringpu Biology
Chopper Biology
Merial
Veterinary
MSD Animal Health
DHN
ChengDu Tecbond
Ceva
Qilu Animal
Among other players domestic and global, Blue Eye Disease Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Blue Eye Disease Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Blue Eye Disease Vaccines, with price, sales, revenue and global market share of Blue Eye Disease Vaccines in 2018 and 2019.
Chapter 3, the Blue Eye Disease Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Blue Eye Disease Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Blue Eye Disease Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Blue Eye Disease Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Blue Eye Disease Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Blue Eye Disease Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Blue Eye Disease Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Overview of Global Blue Eye Disease Vaccines Market
1.4.1 Global Blue Eye Disease Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CAHIC
2.1.1 CAHIC Details
2.1.2 CAHIC Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CAHIC SWOT Analysis
2.1.4 CAHIC Product and Services
2.1.5 CAHIC Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ringpu Biology
2.2.1 Ringpu Biology Details
2.2.2 Ringpu Biology Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ringpu Biology SWOT Analysis
2.2.4 Ringpu Biology Product and Services
2.2.5 Ringpu Biology Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chopper Biology
2.3.1 Chopper Biology Details
2.3.2 Chopper Biology Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Chopper Biology SWOT Analysis
2.3.4 Chopper Biology Product and Services
2.3.5 Chopper Biology Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merial
2.4.1 Merial Details
2.4.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merial SWOT Analysis
2.4.4 Merial Product and Services
2.4.5 Merial Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Veterinary
2.5.1 Veterinary Details
2.5.2 Veterinary Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Veterinary SWOT Analysis
2.5.4 Veterinary Product and Services
2.5.5 Veterinary Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 MSD Animal Health
2.6.1 MSD Animal Health Details
2.6.2 MSD Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 MSD Animal Health SWOT Analysis
2.6.4 MSD Animal Health Product and Services
2.6.5 MSD Animal Health Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 DHN
2.7.1 DHN Details
2.7.2 DHN Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 DHN SWOT Analysis
2.7.4 DHN Product and Services
2.7.5 DHN Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 ChengDu Tecbond
2.8.1 ChengDu Tecbond Details
2.8.2 ChengDu Tecbond Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ChengDu Tecbond SWOT Analysis
2.8.4 ChengDu Tecbond Product and Services
2.8.5 ChengDu Tecbond Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ceva
2.9.1 Ceva Details
2.9.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ceva SWOT Analysis
2.9.4 Ceva Product and Services
2.9.5 Ceva Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Qilu Animal
2.10.1 Qilu Animal Details
2.10.2 Qilu Animal Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Qilu Animal SWOT Analysis
2.10.4 Qilu Animal Product and Services
2.10.5 Qilu Animal Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Blue Eye Disease Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Blue Eye Disease Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Blue Eye Disease Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Blue Eye Disease Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Blue Eye Disease Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Blue Eye Disease Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Blue Eye Disease Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Blue Eye Disease Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Blue Eye Disease Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Blue Eye Disease Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Blue Eye Disease Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Blue Eye Disease Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Blue Eye Disease Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
6.4 France Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Blue Eye Disease Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Blue Eye Disease Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Blue Eye Disease Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7.5 India Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Blue Eye Disease Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Blue Eye Disease Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Blue Eye Disease Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Blue Eye Disease Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Blue Eye Disease Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Blue Eye Disease Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Blue Eye Disease Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Blue Eye Disease Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Blue Eye Disease Vaccines Price by Type (2015-2020)
11 Global Blue Eye Disease Vaccines Market Segment by Application
11.1 Global Blue Eye Disease Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Blue Eye Disease Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Blue Eye Disease Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Blue Eye Disease Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Blue Eye Disease Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Blue Eye Disease Vaccines Market Forecast (2021-2025)
12.2.2 Europe Blue Eye Disease Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Blue Eye Disease Vaccines Market Forecast (2021-2025)
12.2.4 South America Blue Eye Disease Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Blue Eye Disease Vaccines Market Forecast (2021-2025)
12.3 Blue Eye Disease Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Blue Eye Disease Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Blue Eye Disease Vaccines Market Share Forecast by Type (2021-2025)
12.4 Blue Eye Disease Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Blue Eye Disease Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Blue Eye Disease Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Blue Eye Disease Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Blue Eye Disease Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Blue Eye Disease Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. CAHIC Basic Information, Manufacturing Base and Competitors
Table 8. CAHIC Blue Eye Disease Vaccines Major Business
Table 9. CAHIC Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 10. CAHIC SWOT Analysis
Table 11. CAHIC Blue Eye Disease Vaccines Product and Services
Table 12. CAHIC Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 14. Ringpu Biology Blue Eye Disease Vaccines Major Business
Table 15. Ringpu Biology Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 16. Ringpu Biology SWOT Analysis
Table 17. Ringpu Biology Blue Eye Disease Vaccines Product and Services
Table 18. Ringpu Biology Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Chopper Biology Basic Information, Manufacturing Base and Competitors
Table 20. Chopper Biology Blue Eye Disease Vaccines Major Business
Table 21. Chopper Biology Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 22. Chopper Biology SWOT Analysis
Table 23. Chopper Biology Blue Eye Disease Vaccines Product and Services
Table 24. Chopper Biology Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merial Basic Information, Manufacturing Base and Competitors
Table 26. Merial Blue Eye Disease Vaccines Major Business
Table 27. Merial Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 28. Merial SWOT Analysis
Table 29. Merial Blue Eye Disease Vaccines Product and Services
Table 30. Merial Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Veterinary Basic Information, Manufacturing Base and Competitors
Table 32. Veterinary Blue Eye Disease Vaccines Major Business
Table 33. Veterinary Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 34. Veterinary SWOT Analysis
Table 35. Veterinary Blue Eye Disease Vaccines Product and Services
Table 36. Veterinary Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 38. MSD Animal Health Blue Eye Disease Vaccines Major Business
Table 39. MSD Animal Health Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 40. MSD Animal Health SWOT Analysis
Table 41. MSD Animal Health Blue Eye Disease Vaccines Product and Services
Table 42. MSD Animal Health Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. DHN Basic Information, Manufacturing Base and Competitors
Table 44. DHN Blue Eye Disease Vaccines Major Business
Table 45. DHN Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 46. DHN SWOT Analysis
Table 47. DHN Blue Eye Disease Vaccines Product and Services
Table 48. DHN Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 50. ChengDu Tecbond Blue Eye Disease Vaccines Major Business
Table 51. ChengDu Tecbond Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 52. ChengDu Tecbond SWOT Analysis
Table 53. ChengDu Tecbond Blue Eye Disease Vaccines Product and Services
Table 54. ChengDu Tecbond Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Ceva Basic Information, Manufacturing Base and Competitors
Table 56. Ceva Blue Eye Disease Vaccines Major Business
Table 57. Ceva Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 58. Ceva SWOT Analysis
Table 59. Ceva Blue Eye Disease Vaccines Product and Services
Table 60. Ceva Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Qilu Animal Basic Information, Manufacturing Base and Competitors
Table 62. Qilu Animal Blue Eye Disease Vaccines Major Business
Table 63. Qilu Animal Blue Eye Disease Vaccines Total Revenue (USD Million) (2017-2018)
Table 64. Qilu Animal SWOT Analysis
Table 65. Qilu Animal Blue Eye Disease Vaccines Product and Services
Table 66. Qilu Animal Blue Eye Disease Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Blue Eye Disease Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Blue Eye Disease Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Blue Eye Disease Vaccines Sales by Regions (2015-2020) (K Units)
Table 70. Global Blue Eye Disease Vaccines Sales Market Share by Regions (2015-2020)
Table 71. Global Blue Eye Disease Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Blue Eye Disease Vaccines Sales by Countries (2015-2020) (K Units)
Table 73. North America Blue Eye Disease Vaccines Sales Market Share by Countries (2015-2020)
Table 74. North America Blue Eye Disease Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020)
Table 76. Europe Blue Eye Disease Vaccines Sales by Countries (2015-2020) (K Units)
Table 77. Europe Blue Eye Disease Vaccines Sales Market Share by Countries (2015-2020)
Table 78. Europe Blue Eye Disease Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Blue Eye Disease Vaccines Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Blue Eye Disease Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Blue Eye Disease Vaccines Sales by Countries (2015-2020) (K Units)
Table 83. South America Blue Eye Disease Vaccines Sales Market Share by Countries (2015-2020)
Table 84. South America Blue Eye Disease Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Blue Eye Disease Vaccines Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Blue Eye Disease Vaccines Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Blue Eye Disease Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020)
Table 90. Global Blue Eye Disease Vaccines Sales by Type (2015-2020) (K Units)
Table 91. Global Blue Eye Disease Vaccines Sales Share by Type (2015-2020)
Table 92. Global Blue Eye Disease Vaccines Revenue by Type (2015-2020) (USD Million)
Table 93. Global Blue Eye Disease Vaccines Revenue Share by Type (2015-2020)
Table 94. Global Blue Eye Disease Vaccines Sales by Application (2015-2020) (K Units)
Table 95. Global Blue Eye Disease Vaccines Sales Share by Application (2015-2020)
Table 96. Global Blue Eye Disease Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Blue Eye Disease Vaccines Market Share Forecast by Regions (2021-2025)
Table 98. Global Blue Eye Disease Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Blue Eye Disease Vaccines Market Share Forecast by Type (2021-2025)
Table 100. Global Blue Eye Disease Vaccines Sales Forecast by Application (2021-2025)
Table 101. Global Blue Eye Disease Vaccines Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Blue Eye Disease Vaccines Picture
Figure 2. Global Sales Market Share of Blue Eye Disease Vaccines by Type in 2019
Figure 3. Live Vaccines Picture
Figure 4. Killed Vaccines Picture
Figure 5. Blue Eye Disease Vaccines Sales Market Share by Application in 2018
Figure 6. Piglets Picture
Figure 7. Adult Pigs Picture
Figure 8. Global Blue Eye Disease Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Blue Eye Disease Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Blue Eye Disease Vaccines Sales Market Share by Manufacturer in 2019
Figure 29. Global Blue Eye Disease Vaccines Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Blue Eye Disease Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Blue Eye Disease Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Blue Eye Disease Vaccines Revenue Market Share by Regions (2015-2020)
Figure 36. Global Blue Eye Disease Vaccines Revenue Market Share by Regions in 2018
Figure 37. North America Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
Figure 38. Europe Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
Figure 40. South America Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020)
Figure 42. North America Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Blue Eye Disease Vaccines Sales Market Share by Countries (2015-2020)
Figure 44. North America Blue Eye Disease Vaccines Sales Market Share by Countries in 2018
Figure 45. North America Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Blue Eye Disease Vaccines Revenue Market Share by Countries in 2018
Figure 47. United States Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Blue Eye Disease Vaccines Revenue Market Share by Countries in 2019
Figure 53. Germany Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Blue Eye Disease Vaccines Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Blue Eye Disease Vaccines Revenue Market Share by Regions 2019
Figure 61. China Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Blue Eye Disease Vaccines Sales Market Share by Countries in 2019
Figure 68. South America Blue Eye Disease Vaccines Revenue Market Share by Countries in 2019
Figure 69. Brazil Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Blue Eye Disease Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Blue Eye Disease Vaccines Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Blue Eye Disease Vaccines Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Blue Eye Disease Vaccines Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Blue Eye Disease Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Blue Eye Disease Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Blue Eye Disease Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Blue Eye Disease Vaccines Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Blue Eye Disease Vaccines Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Blue Eye Disease Vaccines Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Blue Eye Disease Vaccines Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Blue Eye Disease Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
青耳病ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Blue Ear Pig Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blue Ear Pig Vaccines m…- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- 口蹄疫ワクチンの世界市場（～2026年） Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats. China is the lar…
- mRNAワクチン・治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…